Shaun Decordova

3PUBLICATIONS
54CO-AUTHORS
Tumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 27, 2026
Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma.

|Jul 04, 2020
First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors.

Robert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos

|Jun 14, 2020
Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with BRCA1/2- and Non-BRCA1/2-Mutant Cancers.

Timothy A Yap, Rebecca Kristeleit, Vasiliki Michalarea

Pageof 1

Frequent Collaborators

3 joint publications

Karen Swales

3 joint publications

Udai Banerji

2 joint publications

Nina Tunariu

2 joint publications

Ruth Ruddle